I. Boyle

发表

Serological diagnosis of idiopathic Addison's disease in patients on prolonged prednisolone therapy for steatorrhoea.

R. B. Goudie, A. Ferguson, D. A. Stuart-Smith, 1969, Lancet.

Pseudohypoparathyroidism presenting as severe Parkinsonism.

D. Pearson, I. Fogelman, G. Beastall, 1981, Postgraduate medical journal.

The Acute Renal Tubular Effects of 1,25-Dihydroxycholecalciferol

H. DeLuca, J. Puschett, R. Gray, 1972, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Clinical profile of acute vertebral compression fractures in osteoporosis.

A. Crisp, I. Boyle, U. Patel, 1991, British journal of rheumatology.

Intravenous pamidronate in the treatment of osteoporosis associated with corticosteroid dependent lung disease: an open pilot study.

R. Cowan, S. Gallacher, F. Logue, 1992, Thorax.

An Evaluation of Bone Density and Turnover in Premenopausal Women with Type 1 Diabetes Mellitus

W. Fraser, A. Maccuish, B. M. Fisher, 1993, Diabetic medicine : a journal of the British Diabetic Association.

A survey of treatment attitudes to postmenopausal osteoporosis.

I. Boyle, P. Underwood, 1983, Scottish medical journal.

Abnormalities in mineral metabolism suggestive of parathyroid over-activity in rheumatoid arthritis.

B. F. Allam, W. Buchanan, G. Nuki, 1975, Current medical research and opinion.

Focal osteomalacia due to “low dose” diphosphonate therapy in paget's disease

S. Ralston, B. Boyce, I. Fogelman, 1984 .

Breast Cancer-Associated Hypercalcaemia: A Reassessment of Renal Calcium and Phosphate Handling

S. Ralston, W. Fraser, S. Gallacher, 1990, Annals of clinical biochemistry.

FOCAL OSTEOMALACIA DUE TO LOW-DOSE DIPHOSPHONATE THERAPY IN PAGET'S DISEASE

S. Ralston, B. Boyce, I. Fogelman, 1984, The Lancet.

The role of bone scanning in Paget's disease.

I. Fogelman, D. Carr, I. Boyle, 1981, Metabolic bone disease & related research.

The Bone Scan in Clinical Practice

I. Fogelman, I. Boyle, 1980, Scottish medical journal.

COMPARISON OF THREE INTRAVENOUS BISPHOSPHONATES IN CANCER-ASSOCIATED HYPERCALCAEMIA

S. Ralston, R. Cowan, S. Gallacher, 1989, The Lancet.

Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin.

S. Ralston, M. D. Gardner, I. Boyle, 1986, British medical journal.

The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease.

W. Greig, D. Citrin, I. Fogelman, 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Alteration of the circadian rhythm of intact parathyroid hormone and serum phosphate in women with established postmenopausal osteoporosis

W. Fraser, G. Beastall, S. Gallacher, 2007, Osteoporosis International.

A comparison of the effects of alfacalcidol treatment and vitamin D2 supplementation on calcium absorption in elderly women with vertebral fractures

R. Francis, R. Cowan, G. Beastall, 2005, Osteoporosis International.

Factors predicting the acute effect of pamidronate on serum calcium in hypercalcemia of malignancy

S. Ralston, W. Fraser, R. Cowan, 1992, Calcified Tissue International.

Acute effects of intravenous 1 alpha-hydroxycholecalciferol on parathyroid hormone, osteocalcin and calcitriol in man.

W. Fraser, R. Cowan, S. Gallacher, 1994, European journal of endocrinology.

Clinical and laboratory studies of a new immunoradiometric assay of parathyroid hormone-related protein.

W. Fraser, G. Beastall, S. Gallacher, 1993, Clinical chemistry.

Coincidental occurrence of primary hyperparathyroidism and cancer‐associated hypercalcaemia in a middle‐aged man

W. Fraser, A. Mcnicol, S. Gallacher, 1993, Clinical endocrinology.

A comparison of 10 MHz ultrasound and 201-thallium/99m-technetium subtraction scanning in primary hyperparathyroidism.

J. Mckillop, S. Gallacher, T. Cooke, 1993, Postgraduate medical journal.

A comparison of low versus high dose pamidronate in cancer-associated hypercalcaemia.

S. Ralston, W. Fraser, R. Cowan, 1991, Bone and mineral.

The response of intestinal calcium transport to 25-hydroxy and 1,25-dihydroxy vitamin D in nephrectomized rats.

H. DeLuca, M. Holick, R. Gray, 1972, Endocrinology.

1,24,25-Trihydroxyvitamin D3. A metabolite of vitamin D3 effective on intestine.

H. DeLuca, M. Holick, H. Schnoes, 1973, The Journal of biological chemistry.

Regulation of metabolism of 25-hydroxycholecalciferol by kidney tissue in vitro by dietary calcium.

H. DeLuca, R. Gray, J. Omdahl, 1972, Nature: New biology.

Hypercalcaemia of malignancy: evidence for a nonparathyroid humoral agent with an effect on renal tubular handling of calcium.

S. Ralston, I. Fogelman, R. Cowan, 1984, Clinical science.

A Clinical Appraisal of Calcitonin

I. Boyle, 1970, Scottish medical journal.

Successful localisation of parathyroid adenomata by thallium-201 and technetium-99m subtraction scintigraphy: description of an improved technique

J. Mckillop, I. Fogelman, H. Gray, 2004, European Journal of Nuclear Medicine.

Current problems with rickets and osteomalacia

I. Boyle, 1990 .

The biological activity and metabolism of 24,25-dihydroxyvitamin D 3 .

H. DeLuca, R. Gray, J. Omdahl, 1973, The Journal of biological chemistry.

Changes in calciotrophic hormones and biochemical markers of bone turnover in normal human pregnancy.

W. Fraser, S. Gallacher, A. Jenkins, 1994, European journal of endocrinology.

Vitamin D—An Old Hormone Rediscovered

I. Boyle, 1974, Scottish medical journal.

DEAFNESS DUE TO HYPERVITAMINOSIS D

I. Fogelman, H. Cohen, I. Boyle, 1979, The Lancet.

Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study.

S. Gallacher, I. Boyle, S. Banham, 1992, Thorax.

Failure to detect paramyxovirus sequences in paget's disease of bone using the polymerase chain reaction

S. Ralston, G. Duff, S. Gallacher, 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Histological and electron microprobe studies of mineralisation in aluminium-related osteomalacia.

H. Y. Elder, B. Boyce, M. Mocan, 1992, Journal of clinical pathology.

Contrasting mechanisms of hypercalcemia in patients with early and advanced humoral hypercalcemia of malignancy

S. Ralston, W. Fraser, B. Boyce, 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

A LOW DOSE REGIME OF 1α HYDROXYVITAMIN D3 IN THE MANAGEMENT OF SENILE OSTEOPOROSIS: A PILOT STUDY

I. Fogelman, W. Mcintosh, G. Beastall, 1980, Clinical endocrinology.

SIDE-EFFECTS OF PAMIDRONATE

S. Ralston, S. Gallacher, I. Boyle, 1989, The Lancet.

Do Anticonvulsant Drugs Commonly Induce Osteomalacia?

B. F. Allam, B. Boyce, I. Fogelman, 1982, Scottish medical journal.

PTH and vitamin D responses during treatment of hypomagnesaemic hypoparathyroidism.

S. Ralston, G. Crean, R. Cowan, 1983, Acta endocrinologica.

The effect of 1α‐hydroxyvitamin D3 on the mineralization defect in disodium etidronate‐treated paget's disease — a double‐blind randomized clinical study

S. Ralston, B. Boyce, I. Fogelman, 1987 .

Vitamin D and Ultra Violet Radiation

I. Boyle, 1980, Scottish medical journal.

Association of severe haemophilia A with osteoporosis: a densitometric and biochemical study.

W. Fraser, G. Lowe, R. Cowan, 1994, The Quarterly journal of medicine.

Calcium Control of the In Vivo Biosynthesis of 1,25 Dihydroxyvitamin D 3 : Nicolaysen's Endogenous Factor

H. DeLuca, R. Gray, J. Omdahl, 1972 .

HYPERCALCAEMIC OSTEOMALACIA DUE TO ALUMINIUM TOXICITY

H. Y. Elder, G. S. Fell, B. Boyce, 1982, The Lancet.

Control of 25-hydroxycholecalciferol metabolism by parathyroid glands.

H. DeLuca, M. Holick, M. Garabédian, 1972, Proceedings of the National Academy of Sciences of the United States of America.

Regulation by calcium of in vivo synthesis of 1,25-dihydroxycholecalciferol and 21,25-dihydroxycholecalciferol.

H. DeLuca, R. Gray, I. Boyle, 1971, Proceedings of the National Academy of Sciences of the United States of America.

Thyroid acropachy.

B. Moule, I. Boyle, M. Grant, 1970, Clinical radiology.

The thyroid scan in patients with Hashimoto's disease.

J. A. Boyle, W. Greig, J. Thomson, 1966, Acta endocrinologica.

DIPHOSPHONATES AND INHIBITION OF BONE MINERALISATION

S. Ralston, B. Boyce, I. Fogelman, 1982, The Lancet.

Direct and indirect assessment of the parathyroid hormone response to pamidronate therapy in Paget's disease of bone and hypercalcaemia of malignancy.

S. Ralston, W. Fraser, G. Beastall, 1991, Bone and mineral.

Simple goitre in Glasgow and Dumfries schoolchildren.

J. A. Boyle, W. Greig, E. Mcgirr, 1967, Lancet.

Effect of thyroid ablation on dysthyroid exophthalmos.

W. Greig, E. Mcgirr, J. Thomson, 1969, Proceedings of the Royal Society of Medicine.

Five-year double-blind fluoridated milk study in Scotland.

K. Stephen, I. Boyle, D. Campbell, 1984, Community dentistry and oral epidemiology.

The role of bone scanning in osteomalacia.

W. Greig, J. Mckillop, I. Fogelman, 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A 4-year double-blind fluoridated school milk study in a vitamin-D deficient area

K. Stephen, J. Fyffe, A. Jenkins, 1981, British Dental Journal.

Cancer-Associated Hypercalcemia: Morbidity and Mortality: Clinical Experience in 126 Treated Patients

S. Ralston, J. Campbell, S. Gallacher, 1990 .

Dysthyroid Exophthalmos

W. Greig, E. Mcgirr, J. Thomson, 1969 .

Toxic diffuse goitre in monozygotic twins.

J. A. Boyle, W. Greig, I. Boyle, 1966, Lancet.

The Localisation of Parathyroid Tumours—A Comparison of Computed Tomography with Cervical Vein Hormone Assay

I. Fogelman, G. Beastall, N. McMillan, 1983, Scottish medical journal.

Augmentation of parathyroid 201TI99cm scanning by infusion of trisodium edetate

W. Fraser, J. Mckillop, F. Logue, 1991, Nuclear medicine communications.

Preoperative Localisation of Parathyroid Adenomas

J. Mckillop, I. Boyle, I. Gunn, 1986, Scottish medical journal.

Pre-Operative Localisation of Parathyroid Tumours Using Neck Vein Catheterisation and Radioimmunoassay for Parathyroid Hormone: The Glasgow Experience

B. Boyce, I. Fogelman, R. Cowan, 1983, Scottish medical journal.

Central Nervous System Histiocytosis X — Imaging and Responses to Chemotherapy

D. Hadley, E. Forrest, S. Gallacher, 1993, Scottish medical journal.

Treatment of hypercalcaemia in thyrotoxicosis with aminohydroxypropylidene diphosphonate.

J. Thomson, M. D. Gardner, T. T. Tan, 1988, Postgraduate medical journal.

Semi-quantitative interpretation of the bone scan in metabolic bone disease

D. Citrin, I. Fogelman, I. Hay, 1979, European Journal of Nuclear Medicine.

Bone scan findings in hypervitaminosis D: case report.

W. Greig, B. Boyce, J. Mckillop, 1977, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Absent kidney sign associated with symmetrical and uniformly increased uptake of radiopharmaceutical by the skeleton

W. Greig, J. Mckillop, I. Fogelman, 1977, European Journal of Nuclear Medicine.

Estimation of skeletal involvement in primary hyperparathyroidism. Use of 24-hour whole-body retention of technetium-99m diphosphonate.

I. Fogelman, G. Beastall, R. Bessent, 1980, Annals of internal medicine.

Pseudofracture of the ribs detected by bone scanning.

W. Greig, J. Mckillop, I. Fogelman, 1977, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Skeletal uptake of Tc-99m HEDP in primary hyperparathyroidism.

W. Greig, I. Fogelman, R. Bessent, 1977, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Glucocorticoids and æstrogens in the management of hypercalcaemia

I. Fogelman, I. Boyle, 1980 .

Cytokine and growth factor expression in Paget's disease: analysis by reverse-transcription/polymerase chain reaction.

S. Ralston, S. Gallacher, I. Boyle, 1994, British journal of rheumatology.

Gynaecomastia in chronic renal failure.

J. Briggs, R. Lindsay, R. Luke, 1967, British medical journal.

Serum uric acid values in various states of thyroid function.

W. Buchanan, J. A. Boyle, W. Greig, 1966, Acta rheumatologica Scandinavica.

Immobilization-related hypercalcaemia--a possible novel mechanism and response to pamidronate.

B. F. Allam, S. Ralston, B. Boyce, 1990, Postgraduate medical journal.

The influence of calciotrophic hormones on lymphocyte transformation and interleukin-2 production in human mononuclear cells.

A. Jenkins, I. Boyle, J. Smith, 1990, Journal of clinical & laboratory immunology.

Management of male osteoporosis: report of the UK Consensus Group.

C. Cooper, R. Francis, R. Eastell, 1998, QJM : monthly journal of the Association of Physicians.

HYPERCALCAEMIA AND METASTATIC BONE DISEASE: IS THERE A CAUSAL LINK?

S. Ralston, I. Fogelman, M. D. Gardner, 1982, The Lancet.

Correlation of skeletal uptake of 99mTc-diphosphonate and alkaline phosphatase before and after oral diphosphonate therapy in Paget's disease.

S. Ralston, B. Boyce, I. Fogelman, 1984, Metabolic bone disease & related research.

Problems with osteoporosis.

I. Boyle, 1981, Scottish Medical Journal.

Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy.

S. Ralston, I. Fogelman, M. Gardiner, 1984, British medical journal.

Use of bisphosphonates in hypercalcaemia due to malignancy

S. Ralston, S. Gallacher, F. Dryburgh, 1990, The Lancet.

PATHOGENESIS OF OSTEOPOROSIS

B. Boyce, I. Fogelman, I. Boyle, 1980, The Lancet.

Isolation and identification of 24,25-dihydroxycholecalciferol, a metabolite of vitamin D made in the kidney.

H. DeLuca, M. Holick, R. Gray, 1972, Biochemistry.

The Biological Activity and Metabolism of 24,25-Dihydroxyvitamin D3

H. DeLuca, R. Gray, J. Omdahl, 1973 .

Do oral corticosteroids cause osteoporosis in rheumatoid arthritis?

J. Anderson, W. Buchanan, J. A. Boyle, 1970, Annals of the rheumatic diseases.

1α‐HYDROXYVITAMIN D3 IN PRIMARY HYPERPARATHYROIDISM

B. Boyce, W. Mcintosh, G. Beastall, 1977, Clinical Endocrinology.

The mechanism of adaptation of intestinal calcium absorption to low dietary calcium.

H. DeLuca, R. Gray, R. Schilling, 1971, The Journal of laboratory and clinical medicine.

School microepidemic of tuberculosis.

I. Boyle, S. Banham, K. Anderson, 1992, Thorax.

Bronchial compression as a result of lung herniation after pneumonectomy School microepidemic of tuberculosis

I. Boyle, S. Banham, K. Anderson, 2022 .

Serial bone scans in Paget's disease: Development of new lesions, natural variation in lesion intensity and nature of changes seen after treatment

J. Mckillop, S. Gallacher, I. Boyle, 1990, Nuclear medicine communications.

The effect of 1 alpha-hydroxyvitamin D3 on the mineralization defect in disodium etidronate-treated Paget's disease--a double-blind randomized clinical study.

S. Ralston, B. Boyce, I. Fogelman, 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Pseudogout Associated with the Use of Cyclical Etidronate Therapy

H. Capell, S. Gallacher, I. Boyle, 1991, Scottish Medical Journal.

Relative Contribution of Humoral and Metastatic Factors to the Pathogenesis of Hypercalcaemia and Malignancy

S. Ralston, I. Fogelman, M. Gardiner, 1984 .

PAMIDRONATE AND HYPERCALCAEMIA OF MALIGNANCY

R. Warrell, S. Ralston, L. Beex, 1989, The Lancet.